NCT04163484Completed
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 8 Oct 2024
Brief summary (registry, in English)
The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 156 (actual)
- First submitted
- 25 Oct 2019
- Start date
- 15 Jan 2019
- Primary completion date
- 30 Dec 2022
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT04163484
What you commit to
- Study type: Observational
- Participants enrolled: 156
- From 15 Jan 2019 to the primary completion date, 30 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving nephrotoxic drugs
Other illness
- Other conditions affecting prognosis (oncology, liver failure etc)
Age
- Age less than 18
Other
- Pregnancy, lactation
- Refuse to sign the informed consent
- Contraindications for PCI
- CKD stage 4-5
Who the study is looking for
- Males and females aged 18-80
- Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI
- Intra-arterial injection of iodinated contrast media
- Informed consent
Age in the registry: 18 years to 80 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sechenov University Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.